Skip to main content

Table 2 Effects of theophylline (50 mg/kg bw) on soleus muscle and heart mRNA content of the different proteolytic systems in rats bearing the Yoshida AH-130 ascites hepatoma

From: Theophylline is able to partially revert cachexia in tumour-bearing rats

  

SOLEUS

    

HEART

   

Treatment

C(n = 5)

T(n = 5)

T + TPH(n = 6)

ANOVA

C(n = 5)

T(n = 5)

T + TPH(n = 6)

ANOVA

    

A

B

   

A

B

PROTEOLYTIC SYSTEM

Ubiquitin-dependent

Ubiquitin

100 ± 6

204 ± 15

118 ± 18

0,000

0,001

100 ± 5

302 ± 51

177 ± 32

0,001

0,019

Proteasome subunit C2

100 ± 13

168 ± 10

160 ± 40

ns

ns

100 ± 3

303 ± 47

191 ± 23

0,000

0,010

Proteasome subunit C8

100 ± 5

111 ± 8

97 ± 25

ns

ns

100 ± 3

262 ± 26

164 ± 22

0,000

0,005

E2

100 ± 5

527 ± 129

288 ± 80

0,004

0,063

100 ± 5

224 ± 55

114 ± 19

0,013

0,025

MuRF-1

100 ± 3

171 ± 19

80 ± 26

0,025

0,007

100 ± 3

309 ± 92

177 ± 38

0,015

ns

Atrogin-1

100 ± 8

392 ± 22

362 ± 71

0,002

ns

100 ± 3

161 ± 21

152 ± 21

0,039

ns

Calcium-dependent

m-calpain

100 ± 4

117 ± 23

142 ± 43

ns

ns

100 ± 4

307 ± 58

170 ± 18

0,001

0,009

Lysosomal

Cathepsin-B

100 ± 4

111 ± 8

151 ± 34

ns

ns

100 ± 2

194 ± 40

111 ± 13

0,010

ns

  1. For further details, see the Material and Methods section. The results are expressed as a percentage of controls (T). All data are mean ± SEM. C = non-tumour-bearing rats, T = tumour-bearing rats, T + TPH = tumour-bearing rats treated with theophylline. Statistical significance of the results by two-way analysis of variance (ANOVA) are indicated by: ns (non-significant differences), A (tumour effect), B (treatment effect).